To gain global insights into the role of the well-known repressive splicing regulator PTB, we analyzed the consequences of PTB knockdown in HeLa cells using high-density oligonucleotide splice-sensitive microarrays. The major class of identified PTB-regulated splicing event was PTB-repressed cassette exons, but there was also a substantial number of PTB-activated splicing events. PTB-repressed and PTB-activated exons showed a distinct arrangement of motifs with pyrimidine-rich motif enrichment within and upstream of repressed exons but downstream of activated exons. The N-terminal half of PTB was sufficient to activate splicing when recruited downstream of a PTB-activated exon. Moreover, insertion of an upstream pyrimidine tract was sufficient to convert a PTB-activated exon to a PTB-repressed exon. Our results show that PTB, an archetypal splicing repressor, has variable splicing activity that predictably depends upon its binding location with respect to target exons. 1 1 1 5 a r t i c l e s motifs only within the downstream intron and were associated with weaker 5′ splice sites. Strikingly, we found a similar pattern of PTB CLIP tag enrichment upstream of repressed exons but downstream of activated exons. Overall, our data indicate that PTB shows activity that is dependent on the location at which it binds relative to a target exon, similar to the Nova 32 , Fox 33-35 and Mbnl 36 proteins.
a r t i c l e s Alternative splicing (AS) is the major mechanism that accounts for the much higher complexity of mammalian proteomes compared with the number of protein-coding genes in their genomes. Although much has been learned from the experimental dissection of model systems of alternative splicing, it is often difficult to disentangle the truly general properties that typify a particular program of regulated splicing from those that are peculiar to the particular model system being investigated. One of the major current goals of research on alternative splicing is to try to decipher the underlying logic of coregulated programs of alternative splicing [1] [2] [3] [4] [5] . This type of approach has been enabled by the development of technologies such as splice-sensitive microarrays that allow profiling of large numbers of alternative splicing events (ASEs) in parallel. By comparing the transcriptomes from large numbers of tissues, it is possible to define sets of coregulated exons and then analyze them for the enrichment of sequence motifs in particular locations relative to the regulated exons [6] [7] [8] . A complementary approach is to analyze the contribution of individual splicing regulators to regulated splicing programs by profiling changes in alternative splicing after experimental perturbation of splicing regulator levels. We have used this approach to define a large set of ASEs that are regulated by human polypyrimidine tract-binding protein (PTB) in HeLa cells.
PTB is a heterogeneous nuclear ribonucleoprotein that commonly acts as a repressive splicing regulator 9, 10 as well as influencing other post-transcriptional steps in gene expression 11 . Structurally, PTB consists of four RNA recognition motif (RRM) domains, each of which recognize pyrimidine motifs 12 . The optimal binding site consists of pyrimidine motifs typified by UCUU 13, 14 . Splicing silencer elements containing such motifs have been characterized in introns flanking PTB-repressed exons for example [15] [16] [17] [18] . Proposed mechanisms of repression range from simple competition with U2AF65 binding at the polypyrimidine tract 19, 20 to interference with cross-intron or crossexon splicing complex assembly [21] [22] [23] . In addition, various lines of evidence suggest that PTB-mediated looping of RNA between binding sites may have a role in its repressive activity 12, 24, 25 . By contrast, just the second RRM domain and the following interdomain linker can induce exon skipping when artificially tethered adjacent to an exon 26 . Until recently, there were only sporadic reports of PTB activating some splicing events 27, 28 , possibly by antagonizing other repressors 27, 29, 30 . However, a cross-linking immunoprecipitation coupled with highthroughput sequencing (CLIP-seq) global survey of PTB-binding RNAs in HeLa cells indicated that PTB-repressed and PTB-activated exons could be distinguished by the arrangement of PTB binding sites. PTB binding around regulated exons was associated with repression, whereas PTB binding in the region of the flanking constitutive exons was associated with activation of cassette exons 31 .
Here we report the use of a high-density Affymetrix microarray, featuring probesets corresponding to all well-annotated exons and exon-exon junctions in ~24,000 human genes, to identify ASEs affected by knockdown of PTB in HeLa cells. We identified 196 PTB-repressed events and 67 PTB-activated events. PTB-repressed and PTB-activated exons showed distinct arrangements of enriched sequence motifs. PTB-repressed exons showed enrichment of PTBbinding motifs both within the exons themselves and in the flanking upstream intron but not in the downstream intron. In stark contrast, PTB-activated exons were associated with enrichment of PTB-binding PTB-regulated ASEs will not have been identified (false negatives), the set of PTB-regulated exons was suitable for further analysis.
The PTB-regulated events encompassed most categories of ASE except retained introns ( Fig. 1c) . They included 133 simple cassette exons, 27 exons that were parts of multiple cassettes, 18 mutually exclusive exons from a total of 13 mutually exclusive pairs (we observed reciprocal changes in both members of five mutually exclusive pairs), 32 alternative 3′-terminal exons, five alternative 5′ splice sites and four alternative 3′ splice sites. The majority of events (196 of 263) were upregulated upon PTB knockdown, consistent with PTB's conventional role as a splicing repressor 9, 10 . The remaining 67 were downregulated upon knockdown, implying that they are activated by PTB, as suggested previously 27, 28 . Although some apparent PTBactivated exons may be indirect targets, subsequent motif-enrichment and functional analyses indicated that a substantial proportion are likely to be authentic direct PTB targets (see below).
PTB-regulated mutually exclusive exons
Mutually exclusive splicing events are interesting from the perspective that some special mechanism is required to prevent the two exons from splicing together 40 . All the array predictions of PTB-regulated mutually exclusive splicing were validated by RT-PCR ( Fig. 2 , ref. 37 and data not shown). Of the 13 mutually exclusive pairs, in ten cases, the exon upregulated upon PTB and nPTB knockdown was the downstream of the pair, whereas in three cases, it was the upstream exon. In two cases (C14ORF118 and one pair of ACTN4 exons), the predicted branch point of the downstream exon was sufficiently close to the upstream exon to prevent the two exons from splicing together. In nine cases, the splicing together of the two exons was predicted to lead to NMD, which can lead to the appearance of strict mutually exclusive splicing. We tested whether PTB acted to enforce mutually exclusive behavior of each of these exon pairs by carrying out knockdown of PTB and nPTB in combination with UPF1 (ref. 41) ( Fig. 2 and Supplementary Fig. 1 ). In six cases, PTB and nPTB knockdown led to an increase in the double-included product. However, in no case did double inclusion become the major spliced product. For example, with TPM1 exons 8 and 9, double inclusion increased from 0.8% to 5.8%, whereas single inclusion of exon 9 increased from 3.5% to 47.3% (Fig. 2) . Thus, although PTB acts to repress TPM1 exon 9, it only partially restricts double splicing of exons 8 and 9, indicating that other mechanisms enforce mutually exclusive splicing. Alt. First (1) Alt. 3′SS (2) Alt 5′ss (7) Alt. 3′ terminal ME (11) Multiple (37) Cassette (110)
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Alt. 3′ terminal (10) ME (7) Multiple (7) Cassette (34) To investigate the tissue specificity of PTB regulated exons, we extracted tissue-specific profiles based on data for 24,426 tissueregulated ASEs across 48 human cell lines and tissues 6 . In this manner, we obtained sets of tissue measurements for 1,520 control cassette exons, 69 PTB-repressed cassettes and 20 PTB-activated cassettes. We also extracted PTB and nPTB transcript levels across the tissues and cell lines. Unsupervised hierarchical clustering of tissues and cell lines according to the splicing profiles of control, PTB-activated and PTBrepressed cassettes yielded two distinct clusters: a cluster of brain and striated muscle (heart and skeletal) and one of all remaining tissues ( Fig. 3) . PTB-repressed cassettes were included to highest levels in a r t i c l e s brain and striated muscle. Conversely, PTB-activated cassettes were included at lower levels in these tissues compared to others ( Fig. 3a) .
Moreover, there was a significant inverse correlation between mean inclusion levels of PTB-repressed cassettes and transcript levels of PTB (R = 0.84, P = 2.5 × 10 −14 ) ( Fig. 3b ) across the 48 tissue and cell samples. Conversely, mean inclusion levels of PTB-activated cassettes showed a positive correlation with PTB levels (R = 0.55, P = 3.8 × 10 −5 ). nPTB expression correlates inversely with PTB; consequently, nPTB levels showed direct correlation with the inclusion levels of PTB-repressed cassettes and inverse correlation with PTB-activated cassettes. We repeated these analyses using Affymetrix ExonArray data for 11 human tissues 39 and obtained similar results (data not shown). Consistent with the observed tissue specificity, gene ontology analysis 42 indicated that the most significantly enriched terms for molecular function and biological process were associated with the cytoskeleton, G-protein modulators and membrane traffic ( Supplementary Table 1 ), similar to the enrichment terms noted for PTB-regulated events in N2A cells 27, 43 . Among the PTB-regulated ASEs were cassette events within the genes for both PTB paralogs nPTB and ROD1 (refs. 27,37,43) as well as in the genes of other splicing regulators, such as MBNL2 and SRPK2 (Supplementary Data 1). Indeed, when we repeated gene ontology analysis using a three-fold larger set of predictions produced using ASPIRE 44 , nucleic acids binding protein and pre-mRNA processing were significantly enriched terms (P = 2.76 × 10 −11 for for nucleic acid binding; P = 4.91 × 10 −2 for mRNA processing), supporting previous observations that splicing regulators form complex regulatory networks 34 . A number of the PTB-regulated exons have also previously been identified to be misregulated in cancer, including mutually exclusive PKM2 (ref. 45) , TPM1 and ACTN1 exons 46 , which may be related to elevated PTB levels in some cancers [47] [48] [49] .
Features of PTB-regulated exons
We analyzed the 208 PTB-regulated ASEs for various splice-site sequence features ( Table 1) . PTB-repressed cassettes and 3′-end exons differed from control and PTB-activated sets in having longer, higher-scoring polypyrimidine tracts. They also had significantly longer AG dinucleotide exclusion zones upstream of the 3′ splice site, which is indicative of distant branch-point location 50 . In contrast, PTB-activated cassettes had significantly weaker 5′ splice sites by two out of three separate measures of 5′ splice-site strength.
We were next interested in deciphering the regulatory code of PTB. Though it is known that PTB binds sequences typified by 'TCTT' , we applied a naïve approach and looked for enrichment of k-mers, 4-to 7-nucleotide (nt) RNA words, within the PTB-regulated exons and in the adjacent 200 nt of each flanking intron. We observed significant enrichment of UC-rich k-mers within PTB-repressed exons and in the 200-nt upstream intronic flank ( Fig. 4a,b , left and middle). Clustering of enriched k-mers revealed classical optimal CU-rich PTB-binding motifs in the exons and upstream intronic flank (Fig. 4c , left and middle). In contrast, only eight motifs were enriched within the downstream intronic flank of PTB-repressed exons. The two most significantly enriched motifs (UGCU and UGCATG) correspond to optimal binding sites for the Mbnl 51 and Fox proteins 52 , respectively (Fig. 4b, right) . Two other enriched motifs also contained UGCU, and three others contained part of the FOX hexamer. Clustering of the eight motifs produced a hybrid motif resembling both Fox and Mbnl sites (Fig. 4b,c, right) . To pursue this further, we extracted 3,547 Fox2 CLIP tags 34 and looked for overlap with PTB-regulated and control exons. Whereas 8.9% of PTB-repressed exons overlapped with Fox2 tags, this was true of only 1.6% of control exons, a 5.6-fold enrichment (exact Fisher test, P = 1.33 × 10 −6 ). Thus, PTB-repressed exons are significantly associated with observed Fox2 binding.
We next analyzed the density of PTB binding sites at positions along the 200 nt of flanking intron and within the exons themselves. The analysis included flanking constitutive exons and their adjacent 200-nt intron flank, but we found no major enrichments in these areas (Supplementary Fig. 2) . We defined PTB binding sites either as any stretch consisting of YTCY or YCTY (where Y stands for pyrimidine) or by matches to YCTN 1-6 CTN 3-8 YCT (where N represents any nucleotide) 12 . We obtained essentially identical results using the two methods. We observed a peak of PTB sites within the first 20 nt upstream of control exons. In contrast, the PTBrepressed exons showed a higher density of PTB sites extending further upstream, approaching background levels at ~−120 nt (Fig. 4d, left) . The density of PTB sites was higher within PTB-repressed exons than that for control exons with no obvious peaks ( Fig. 4d, center) . On the downstream side of repressed exons, the density of PTB sites was the same as that of control cassettes. Similar to the cassette exons, alternative 3′-terminal PTB-repressed exons (but not alternative 3′-terminal PTB-activated exons) also showed an elevated density of PTB sites in both the upstream intron flank and the exons themselves (data not shown). The highest density of downstream PTB motifs was associated with PTB-activated cassettes ( Table 1) , although this apparent enrichment did not pass a test of significance (P = 0.063). When we restricted our analysis to the 100 nt adjacent to the exon, the enrichment of downstream PTB motifs was significant (P = 0.02). To pursue this further, we looked for k-mer enrichment within the PTB-activated exons and their flanking regions (Fig. 5) . Ten k-mers were significantly enriched on the downstream side of the PTB-activated exons, seven of which were pyrimidine rich. The most significantly enriched motif (1.8-fold, P = 2.96 × 10 −6 ) was the optimal PTB-binding motif TCTT 18 , and clustering of enriched motifs revealed a similar motif (Fig. 5c ). This suggests that exons that are downregulated upon PTB and nPTB knockdown are authentic targets of activation by PTB. The enrichment of PTB sites at this location could be connected with weaker 5′ splice sites of PTBactivated exons ( Table 1) . We observed no motif enrichment within the exons, whereas on the upstream side, the enriched motifs resembled a CUG-BP-and ETR-3-like factor protein binding site 53 . a r t i c l e s
PTB represses via exon splicing silencers
The observed enrichment of PTB-binding motifs within, but not downstream of, PTB-repressed exons was unexpected. We therefore analyzed individual cases with predicted PTB-dependent exon splicing silencers (ESS). ANXA7 exon 6 has extended pyrimidine tracts with a number of potential PTB binding motifs (Fig. 6a) . We cloned the exon along with 200 nt of flanking introns into a GFP-based exontrapping vector. We transfected constructs into HeLa cells and analyzed splicing by RT-PCR under normal conditions and in response to PTB and nPTB knockdown. Inclusion of ANXA7 exon 6 was PTB dependent, increasing from 3.9% to 67% inclusion upon PTB and nPTB knockdown (Fig. 6b) . Three point mutations in the exon were designed to impair PTB binding while avoiding the creation of splicing enhancers 54 . UV cross-linking of exon probes in HeLa nuclear extract showed that these mutations abolished PTB cross-linking ( Fig. 6c , immunoprecipitation of PTB not shown). Electrophoretic mobility shift assay and supershift with PTB antibodies showed that the major gel-shifted complex contained PTB (Fig. 6d,e ). Moreover, this complex formed on the mutant RNA only with higher levels of nuclear extract, indicating lower affinity for PTB ( Fig. 6d) . Consistent with the exonic PTB binding site acting as an ESS, the mutations caused an increase of exon inclusion from 3.9% to 46% (Fig. 6b) . The mutant construct remained responsive to PTB and nPTB knockdown, presumably reflecting the presence of additional PTB binding sites within and upstream of the exon. We made similar observations with an exon in the MTDH gene (data not shown). These data support the prediction from motif enrichment that PTB commonly acts as a repressor by binding to ESSs.
PTB activation via downstream intronic splicing enhancer
A key insight from the bioinformatic analyses was the enrichment of PTB-binding motifs downstream of PTB-activated exons. To investigate the possible role of downstream PTB-binding intronic splicing enhancers (ISEs), we selected an exon (chr14:55,209,643-55,209,726) from the KTN1 gene ( Fig. 7a) , which showed decreased inclusion upon PTB knockdown (Fig. 7b) . This effect was reproduced in the exon-trapping vector, with a 94% to 75% decrease (Fig. 7c , WT construct). We identified two pyrimidine-rich blocks, Py1 and Py2, downstream of the exon (Fig. 7a) . Deletion of Py1 (ΔPy1) had very little effect on exon inclusion under control conditions. In contrast, mutant ΔPy2 had lower levels of exon inclusion (~75%) and was unaffected by PTB knockdown. This indicates that the Py2 element has PTB-dependent ISE activity. The combined deletion ΔPy1,2
further reduced exon inclusion to 37%, showing that, in the absence of the Py2 ISE, Py1 can also activate exon inclusion. A number of well-studied PTB-repressed exons have PTB-binding elements on both sides of the exon 15, 17, 55 , whereas the KTN1 exon has only a downstream site. We next asked if we could convert a PTB-activated to a PTB-repressed exon by inserting an upstream PTB-binding element. To this end, we created the PyUP series of mutants in which we inserted a pyrimidine-rich tract (from ANXA7, Fig. 6, and Supplementary Fig. 3 ) or a nonrelated (nrs) sequence as a control sequence 68 nt upstream of the KTN1 exon. We combined these insertions in the upstream intron with either wild-type, ΔPy1, ΔPy2 or ΔPy1,2 versions of the downstream intron. Insertion of the PyUP, but not the control sequence, led to 70% exon skipping, consistent with insertion of an upstream intronic splicing silencer (Fig. 7d, lanes 1-3) . The same effect was seen when we combined the upstream insertions with the ΔPy1 downstream intron ( Fig. 7d lanes  4-6) . The effect of the PyUP insertion was less dramatic in the context of the ΔPy2 downstream intron (Fig. 7d, lanes 7-9) , suggesting that the full activity of the PyUP intronic splicing silencer is partially dependent on Py2. In the context of the ΔPy1,2 downstream intron, insertion of PyUP had very little effect (Fig. 7d, lanes 10-12) , consistent with previous reports that PTB-mediated repression frequently requires more than one PTB-binding element 15, 24, 25 . Moreover, although the Py2 element has ISE activity in the context of the wild-type or nrs insertion in the upstream intron (Fig. 7d, compare lanes 1 and 7 as well as 3 and 9 ), Py2 has silencer activity in the context of the PyUP insertion, albeit modestly so (Fig. 7d,  compare lanes 2 and 8) . We tested the dependency of the PyUP series of constructs on PTB by RNA interference of PTB and nPTB (Fig. 7e) . Whereas the WT and nrs UP constructs showed decreased exon inclusion upon PTB knockdown (Fig. 7e,  lanes 1, 2, 5 and 6 ), the constructs with PyUP were, as expected, repressed by PTB (Fig. 7e,  lanes 3, 4, 9 and 10 ). Constructs without upstream or downstream PTB sites were unresponsive to PTB knockdown (Fig. 7e, lanes 7,  8, 11 and 12 ). Paradoxically, construct PyUP ΔPy1,2 responded to PTB knockdown with increased exon inclusion (Fig. 7e, lanes 9 and  10) even though ΔPy1,2 itself did not respond to PTB knockdown (Fig. 7e, lanes 7 and 8) and insertion of PyUP into ΔPy1,2 (Fig. 7e,  lanes 7 and 9) did not lead to increased exon skipping. Formally, comparing ΔPy1,2 with PyUP ΔPy1,2, the PyUP element has no activity in control conditions (Fig. 7e, lanes 7 and 9) but acts as an ISE under PTB knockdown conditions (Fig. 7e, lanes 8 and 10) . A possible explanation for the behavior of PyUP ΔPy1,2, is that PTB binds the PyUP element but does not repress, consistent with the requirement for more than one PTB-binding element for repression 15 . However, in the absence of PTB, the element may be able to bind one or more other proteins that cause activation of splicing. Nevertheless, taken together, these results suggest that the activity of an upstream PTB binding site has a repressive activity that is dominant over downstream PTB-dependent ISEs.
A minimal PTB splicing activator domain
We next tested whether downstream activation by PTB could be restored by artificial tethering using MS2 coat protein fusions (Fig. 8) . Replacement of Py2 with an MS2 coat protein binding hairpin (ΔPy2 MS2) reduced exon inclusion from 95% to 63%, a slightly larger effect than that of simple deletion of Py2 (Fig. 8b, lanes 1-3) . Co-transfection with PTB4-MS2 increased exon inclusion from 63% to 83% (Fig. 8b, lane 4) , whereas MS2 coat protein alone had no effect (Fig. 8b, lane 9) . A fusion of MS2 to the splicing repressor hnRNPA1 (ref. 56) led to enhanced exon skipping (Fig. 8b, lane 10) , showing the specificity of activation by PTB recruitment. We next tested four deletion mutants of PTB fused to MS2 (Fig. 8a) , all of which were expressed to similar levels (Fig. 8b, bottom) . The mutations comprised deletions of two or more of the RRM domains 12 as well as the a r t i c l e s interdomain linker between RRM2 and RRM3, which contains the 26-residue insert characteristic of the PTB4 isoform. Strikingly, fusion proteins RRM12L and RRM2L both increased exon inclusion similarly to full-length PTB (Fig. 8b, lanes 5 and 7) . In contrast, RRM12 was without effect (Fig. 8b, lane 6) , showing the importance of the linker between RRM2 and RRM3. The C-terminal RRM34 had an activity opposite to that of full-length PTB, producing slightly lower levels of exon inclusion (Fig. 8b, lane 8) . Thus, the minimal domain of PTB that is sufficient to activate the KTN1 exon is RRM2 combined with the following interdomain linker. Strikingly, this is identical to the minimal domain that acted as a splicing repressor domain when tethered adjacent to Tpm1 exon 3 (ref. 26) .
DISCUSSION
The most striking insight provided by our analyses is that, like Nova 32 , Fox [33] [34] [35] and Mbnl 36, 51 proteins, PTB shows positiondependent splicing activity ( Fig. 9) . When binding upstream or within a cassette exon, it acts as a repressor, but when bound only on the downstream side, it activates inclusion. The position-dependent activity correlates with splice-site features. PTB-activated exons tend to have weaker 5′ splice sites than those of control cassette exons, whereas PTBrepressed exons have longer and stronger polypyrimidine tracts ( Table 1) .
Our results contrast with a recent CLIP analysis of PTB targets in HeLa cells 31 , where it was also found that the position of PTB binding differed markedly between PTBrepressed and PTB-activated cassette exons, but the resultant activity map and model for PTB activation differ from ours. For PTBrepressed exons, they observed enrichment . The differences may also relate to the methods used to identify PTB-regulated events. The CLIP-based pipeline produced a set of 22 validated PTB-regulated ASEs from the 10,372 genes containing PTB CLIP tags. Of these, nearly half (10/22) were activated by PTB, which contrasts with the generally higher prevalence of PTB repression and suggests that the CLIP pipeline may have an unintentional built-in bias that leads to identification of a subset of PTB-regulated ASEs. Consistent with this suggestion, only 14 PTB-repressed exons, and not a single PTB-activated exon, were shared between the two datasets.
To address the differences between the two experimental approaches and datasets, we combined the CLIP-seq data 31 (GEO GSE19323) with our datasets of regulated ASEs. We calculated the mean number of reads per nucleotide across our three datasets of PTB-repressed, PTB-activated and control exons (Fig. 9a, top) . The map of CLIP tag density closely resembled the motif enrichment that we had already observed ( Fig. 9a and Supplementary Fig. 2) . To ensure that these enrichments did not arise from a small number of highly expressed transcripts, we calculated the percentage of exons in each class with at least one CLIP tag in the corresponding transcript region. We again observed the most significant enrichments immediately downstream of activated exons, upstream of repressed exons and within repressed exons (Fig. 9a, bottom) . In addition, many other regions of the PTBregulated exons showed increased incidence of PTB-binding compared to control cassette exons. Finally, we determined the percentage of PTB-regulated exons in the earlier study 31 with at least one CLIP tag within or adjacent to the exon (Supplementary Fig. 4) . Again, the highest incidence of CLIP tags occurred immediately downstream of PTB-activated exons. Additional support for our model of direct activation by PTB is also provided by the KTN1 minigene constructs, in which all the sequence elements necessary for PTB activation were shown to lie within 200 nt of the exon (Figs. 7 and 8) . Nevertheless, it appears that this archetypal splicing repressor is able to activate cassette exons in at least two ways: by kinetically slowing splicing at flanking constitutive splice sites 31 and by direct activation.
The fact that PTB-activated exons have weaker 5′ splice sites ( Table 1) suggests that PTB may promote U1 small nuclear RNP (snRNP) binding. Indeed, activation of U1 snRNP binding has been suggested as a general mechanism for downstream ISEs 57 . In the case of activation by TIA1, a direct interaction with U1C protein assists U1 snRNP binding 58 . A striking finding that should provide clues to the mechanism of activation was the identification of a minimal activation domain of PTB consisting of the second RRM domain and the following interdomain linker (Fig. 8) . This is identical to the minimal repressor domain when tethered downstream of Tpm1 exon 3 (ref. 26 ). RRM2 interacts not only with RNA 12 but also with [S/G][I/L]LGxxP peptide motifs in the corepressor protein Raver1 (ref. 59 ). It will be of interest to determine whether the minimal domain uses the same molecular surfaces and interacting partners for activation and repression. An alternative possibility is that RRM2 may interact with other proteins containing [S/G][I/L]LGxxP motifs. By characterizing minimal effector domains and their functional targets, we should be able to address the more general issue of why regulators such as PTB, Fox and Nova activate splicing when bound downstream but repress when bound upstream.
We also gained insights into the intensively investigated repressor activity of PTB. Analysis of numerous PTB-regulated exons has identified PTB-binding silencer elements most frequently in upstream introns but also in downstream introns and within the exons themselves 10 . Analysis of large datasets (>20,000) of tissue-regulated exons has shown enrichment of PTB-like motifs up to 150 nt upstream of exons that are activated in striated muscle and brain but not within or downstream of the exons 6, 8 . The enrichment of PTB motifs within PTB-repressed exons (Fig. 4) is consistent with the general depletion of PTB binding from exons revealed by genomic SELEX 14 . In contrast to our findings, several well-studied model PTB-regulated exons have PTB binding sites flanking the exons 15, 17, 55 , and models for PTB-mediated repression consequently often involve the looping out of entire exons between PTB bound at flanking sites 10, 12 . Our data suggests that such looping might more commonly occur between the exon and upstream intron rather than between the flanking introns.
PTB has been well characterized as a repressor of neuronally specific exons 27, 43 . By combining our set of PTB-regulated exons with published exon-level expression data 6 , we found that exons that are regulated by PTB show not only neuronal but also striated muscle specificity (Fig. 3) . This adds direct evidence to the association that was previously noted between muscle-and brain-specific exons and enrichment of PTB binding sites upstream of such exons [5] [6] [7] [8] . Regulation by PTB contrasts with the Fox proteins, which are also associated with neuron-and muscle-specific splicing but are expressed at high levels in those tissues. In contrast, it is lower levels of PTB that contribute to muscle-and brain-specific exon inclusion. The association of PTB-repressed exons with downstream Fox and Mbnl motifs (Fig. 5) , a position associated with activation of splicing 6, 8, [33] [34] [35] [36] 51 , indicates that a subset of muscle-and neuron-specific exons are coregulated by the withdrawal of PTB-mediated repression combined with activation by Fox or Mbnl proteins.
In identifying PTB targets in HeLa cells, we needed to knock down not just PTB but also nPTB, which is upregulated upon PTB knockdown and compensates for the loss of PTB in proteomic analyses 37 . However, PTB and nPTB are not fully redundant. The replacement of PTB by nPTB is responsible for a substantial fraction of alternative splicing changes that occur during neurogenic differentiation 27,43 . One study 27 was able to classify exons in mouse N2A cells that were regulated by PTB, nPTB or both proteins. It will be of future interest to determine whether these different classes of exons show distinct activity maps for PTB and nPTB binding.
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